Barbed vs Non-Barbed Sutures for Emergency Abdominal Surgery
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, if you are on chronic immunosuppressive medications, you would not be eligible to participate.
What data supports the effectiveness of using triclosan-coated barbed sutures for emergency abdominal surgery?
Is it safe to use barbed and triclosan-coated sutures in emergency abdominal surgery?
Research shows that triclosan-coated sutures, including barbed ones, are generally safe and can help reduce the risk of surgical site infections (SSIs) in abdominal surgeries. These sutures are designed to improve wound healing by evenly distributing tension and enhancing blood supply to the wound edges.12567
How do barbed and triclosan-coated sutures differ from other treatments for preventing infections in emergency abdominal surgery?
Barbed sutures distribute tension evenly, which can improve blood supply and healing, while triclosan-coated sutures have antibacterial properties that help reduce surgical site infections. This combination is unique because it addresses both mechanical and bacterial factors in wound healing, unlike traditional sutures that may not have these features.12368
What is the purpose of this trial?
This randomized control trial aims to compare the efficacy of triclosan-coated barbed suture (TCB) versus conventional non-barbed polydioxanone (PDS) suture in the closure of the abdominal fascia after emergency exploratory laparotomy. The study addresses the common complications of incisional surgical site infections (SSI) and fascial dehiscence (FD) following emergency exploratory laparotomy. The primary objective is to assess the effectiveness of triclosan-coated barbed suture and conventional non-barbed suture in reducing the rates of incisional SSI and FD within 30 days postoperatively. The study population comprises adult patients undergoing emergent laparotomy for traumatic injuries or acute intraabdominal pathology. This prospective, single-blinded randomized control trial will be conducted at Los Angeles General Medical Center. Patients will be randomized to receive either triclosan-coated barbed suture or conventional non-barbed suture for abdominal fascial closure, with a standard closure technique employed. Patients will be followed up for 30 days postoperatively to monitor surgical site infections, fascial dehiscence, and other outcomes. Statistical analysis will be conducted to compare outcomes between the study arms, assessing the efficacy of triclosan-coated barbed suture in reducing the incidence of SSI and FD, along with secondary outcomes.
Research Team
Matthew Martin, MD
Principal Investigator
Los Angeles General Medical Center
Eligibility Criteria
Adults aged 18+ needing emergency exploratory laparotomy for trauma or acute abdominal issues, who can have their abdomen fully closed during surgery. Excludes those with multiple surgeries planned, incarcerated individuals, preexisting connective tissue diseases or hernias, pregnant women, minors, immune deficiencies, chronic immunosuppression medication users, nosocomial infections or pre-existing hernia.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo emergency exploratory laparotomy with abdominal fascial closure using either triclosan-coated barbed suture or conventional non-barbed suture
Follow-up
Participants are monitored for surgical site infections, fascial dehiscence, and other outcomes
Extended Follow-up
Participants' hospital and ICU length of stay are monitored, along with any unplanned reoperations
Treatment Details
Interventions
- Conventional Non-Barbed Suture
- Triclosan-coated Barbed Suture
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor